RELAY THERAPEUTICS INC (RLAY) Stock Analyst Earnings Estimates
NASDAQ:RLAY - Nasdaq - US75943R1023 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.38M -54.46% | 25.546M 1,751.16% | 10.007M -60.83% | 11.767M 17.59% | 11.741M -0.22% | 22.395M 90.74% | 34.547M 54.26% | 141.51M 309.62% | 300.46M 112.32% | 559.49M 86.21% | 725.96M 29.75% | |
| EBITDA YoY % growth | -295.15M 15.41% | -367.731M -24.59% | -367.004M 0.20% | -361.116M 1.60% | -372.106M -3.04% | -348.309M 6.40% | -274.492M 21.19% | -48.787M 82.23% | 85.792M 275.85% | 268.4M 212.85% | 367.49M 36.92% | |
| EBIT YoY % growth | -299.28M 15.18% | -373M -24.63% | -372.468M 0.14% | -358.044M 3.87% | -361.746M -1.03% | -354.104M 2.11% | -304.123M 14.11% | -214.254M 29.55% | -74.106M 65.41% | 266.61M 459.77% | 365.96M 37.26% | |
| Operating Margin | -21,686.96% | -1,460.11% | -3,722.07% | -3,042.78% | -3,081.05% | -1,581.17% | -880.32% | -151.41% | -24.66% | 47.65% | 50.41% | |
| EPS YoY % growth | -2.60 32.47% | -2.80 -7.69% | -2.39 14.64% | -1.91 20.29% | -1.86 2.32% | -1.91 -2.50% | -1.34 29.77% | -0.89 33.75% | -0.21 75.86% | 1.08 604.76% | 1.51 39.62% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.48 23.11% | -0.45 -0.95% | -0.44 5.27% |
| Revenue Q2Q % growth | 51K | 4.141M | 33.997K -99.56% |
| EBITDA Q2Q % growth | -98.303M -6.57% | -95.146M -19.66% | -77.265M 7.65% |
| EBIT Q2Q % growth | -89.967M 6.64% | -86.212M -1.45% | -84.39M 0.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.41 40.58% | -0.50 | 0.09 | 18.23% |
| Q1 2025 Q2Q % growth | -0.46 25.81% | -0.50 | 0.04 | 7.59% |
| Q4 2024 Q2Q % growth | -0.45 32.84% | -0.57 | 0.12 | 21.46% |
| Q3 2024 Q2Q % growth | -0.63 -16.67% | -0.78 | 0.15 | 19.53% |
| Q2 2024 Q2Q % growth | -0.69 14.81% | -0.75 | 0.06 | 7.69% |
| Q1 2024 Q2Q % growth | -0.62 20.51% | -0.72 | 0.10 | 13.77% |
| Q4 2023 Q2Q % growth | -0.67 -19.64% | -0.74 | 0.07 | 9.82% |
| Q3 2023 Q2Q % growth | -0.54 28.95% | -0.85 | 0.31 | 36.27% |
| Q2 2023 Q2Q % growth | -0.81 -14.08% | -0.83 | 0.02 | 2.64% |
| Q1 2023 Q2Q % growth | -0.78 -36.84% | -0.71 | -0.07 | -10.62% |
| Q4 2022 Q2Q % growth | -0.56 9.68% | -0.72 | 0.16 | 21.82% |
| Q3 2022 Q2Q % growth | -0.76 -15.15% | -0.72 | -0.04 | -5.60% |
| Q2 2022 Q2Q % growth | -0.71 66.19% | -0.64 | -0.07 | -10.74% |
| Q1 2022 Q2Q % growth | -0.57 -21.28% | -0.63 | 0.06 | 9.62% |
| Q4 2021 Q2Q % growth | -0.62 -188.57% | -0.59 | -0.03 | -5.10% |
| Q3 2021 Q2Q % growth | -0.66 -29.41% | -0.65 | -0.01 | -1.33% |
| Q2 2021 Q2Q % growth | -2.10 65.35% | -0.46 | -1.64 | -351.78% |
| Q1 2021 Q2Q % growth | -0.47 | -0.49 | 0.02 | 4.99% |
| Q4 2020 Q2Q % growth | 0.70 | 0.17 | 0.53 | 307.70% |
| Q3 2020 Q2Q % growth | -0.51 | -0.35 | -0.16 | -44.51% |
| Q2 2020 Q2Q % growth | -6.06 | -0.68 | -5.38 | -796.78% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 680K | 61.2K | 618.8K | 1,011.11% |
| Q1 2025 Q2Q % growth | 7.679M -23.26% | 10.2K | 7.669M | 75,184.31% |
| Q4 2024 Q2Q % growth | 6.202M | -6.202M | -100.00% | |
| Q3 2024 Q2Q % growth | -100.00% | 81.6K | -81.6K | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 81.6K | -81.6K | -100.00% |
| Q1 2024 Q2Q % growth | 10.007M 4,327.88% | 79.336K | 9.928M | 12,513.51% |
| Q4 2023 Q2Q % growth | 25.546M -100.00% | 129.815K | -129.815K | -100.00% |
| Q3 2023 Q2Q % growth | 25.202M 7,312.35% | 375.697K | 24.826M | 6,608.07% |
| Q2 2023 Q2Q % growth | 119K -67.84% | 706.86K | -587.86K | -83.16% |
| Q1 2023 Q2Q % growth | 226K -46.19% | 191.76K | 34.24K | 17.86% |
| Q4 2022 Q2Q % growth | 250K -56.14% | 3.366M | -3.116M | -92.57% |
| Q3 2022 Q2Q % growth | 340K -49.25% | 1.689M | -1.349M | -79.87% |
| Q2 2022 Q2Q % growth | 370K -55.95% | 1.967M | -1.597M | -81.19% |
| Q1 2022 Q2Q % growth | 420K -55.79% | 170.003K | 249.997K | 147.05% |
| Q4 2021 Q2Q % growth | 570K -99.31% | 3.917M | -3.347M | -85.45% |
| Q3 2021 Q2Q % growth | 670K | 109.283K | 560.717K | 513.09% |
| Q2 2021 Q2Q % growth | 840K | 6.8M | -5.96M | -87.65% |
| Q1 2021 Q2Q % growth | 950K | 4.151M | -3.201M | -77.11% |
| Q4 2020 Q2Q % growth | 82.65M | 37.4M | 45.25M | 120.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.58% | 0% | 10.12% |
| Revenue | 0% | -98.01% | 0% | 36.26% |